Margaret Tempero

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Debiopharm
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Geistlich Pharma
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Global Bio Access Fund
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    IPSEN Biopharma, Inc.
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Mirati Therapeutics Inc.
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ONCOLYTICS
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merus
    Topic:
    Advisory Board
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Advisory Board
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Global Bio Access Fund
    Topic:
    SAB
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    PEPTOMYC, S.L.
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies